{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T06:12:56Z","timestamp":1786515176944,"version":"build-2736575974"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.cca.2015.07.030","type":"journal-article","created":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T16:53:49Z","timestamp":1438448029000},"page":"43-48","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["An update on laboratory diagnosis in myasthenia gravis"],"prefix":"10.1016","volume":"449","author":[{"given":"Joel","family":"Oger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Frykman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2015.07.030_bb0005","author":"Oger"},{"issue":"6","key":"10.1016\/j.cca.2015.07.030_bb0010","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1001\/archneur.63.6.851","article-title":"Neuromyelitis optica in patients with myasthenia gravis who underwent thymectomy","volume":"63","author":"Kister","year":"2006","journal-title":"Arch Neurol"},{"issue":"6","key":"10.1016\/j.cca.2015.07.030_bb0015","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1136\/archdischild-2013-304788","article-title":"How common is childhood myasthenia? The UK incidence and prevalence of autoimmune and congenital myasthenia","volume":"99","author":"Parr","year":"2014","journal-title":"Arch Dis Child"},{"issue":"10","key":"10.1016\/j.cca.2015.07.030_bb0020","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1172\/JCI119048","article-title":"Association of arthrogryposis multiplex congenita with maternal antibodies inhibiting fetal acetylcholine receptor function","volume":"98","author":"Riemersma","year":"1996","journal-title":"J Clin Invest"},{"issue":"17","key":"10.1016\/j.cca.2015.07.030_bb0025","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1212\/WNL.0b013e318217e735","article-title":"Increasing incidence of myasthenia gravis among elderly in British Columbia, Canada","volume":"76","author":"Pakzad","year":"2011","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.cca.2015.07.030_bb0030","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/mus.23964","article-title":"Late-onset myasthenia gravis: a review when incidence in older adults keeps increasing","volume":"48","author":"Alkhawajah","year":"2013","journal-title":"Muscle Nerve"},{"issue":"5","key":"10.1016\/j.cca.2015.07.030_bb0035","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1212\/WNL.33.5.604","article-title":"In vitro synthesis of antibodies to acetylcholine receptor by peripheral blood mononuclear cells of patients with myasthenia gravis","volume":"33","author":"Lisak","year":"1983","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.cca.2015.07.030_rf0140","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1212\/WNL.56.4.572","article-title":"In myasthenia gravis cells from atrophic thymus secrete acetylcholine receptor antibodies","volume":"56","author":"Katzberg","year":"2001","journal-title":"Neurology"},{"issue":"1\u20132","key":"10.1016\/j.cca.2015.07.030_rf0145","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0022-510X(02)00226-5","article-title":"In myasthenia gravis, clinical and immunological improvement post-thymectomy segregate with results of in vitro antibody secretion by immunocytes","volume":"202","author":"Katzberg","year":"2002","journal-title":"J Neurol Sci"},{"issue":"3","key":"10.1016\/j.cca.2015.07.030_bb0045","first-page":"453","article-title":"Myasthenia gravis. Antibodies to an acid-soluble antigen in striated muscle","volume":"10","author":"Aarli","year":"1972","journal-title":"Clin Exp Immunol"},{"issue":"4","key":"10.1016\/j.cca.2015.07.030_bb0055","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1159\/000324915","article-title":"Repetitive nerve stimulation of facial and hypothenar muscles: relative sensitivity in different myasthenia gravis subgroups","volume":"65","author":"Zambelis","year":"2011","journal-title":"Eur Neurol"},{"issue":"1","key":"10.1016\/j.cca.2015.07.030_bb0060","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/mus.20435","article-title":"Single-fiber EMG with a concentric needle electrode: validation in myasthenia gravis","volume":"33","author":"Sarrigiannis","year":"2006","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.cca.2015.07.030_bb0065","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1136\/jnnp.58.1.85","article-title":"An improved diagnostic assay for Lambert\u2013Eaton myasthenic syndrome","volume":"58","author":"Motomura","year":"1995","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"10.1016\/j.cca.2015.07.030_bb0070","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/ana.410290313","article-title":"Calcium channel autoantibodies in the Lambert\u2013Eaton myasthenic syndrome","volume":"29","author":"Leysm","year":"1991","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.cca.2015.07.030_bb0075","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0022-510X(96)05303-8","article-title":"Incidence of serum anti-P\/Q-type and anti-N-type calcium channel autoantibodies in the Lambert\u2013Eaton myasthenic syndrome","volume":"147","author":"Motomura","year":"1997","journal-title":"J Neurol Sci"},{"issue":"1","key":"10.1016\/j.cca.2015.07.030_bb0080","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/(SICI)1097-4598(199901)22:1<119::AID-MUS19>3.0.CO;2-5","article-title":"Dalmau J.P\/Q-type voltage-gated calcium channel antibodies in paraneoplastic disorders of the central nervous system","volume":"22","author":"Voltz","year":"1999","journal-title":"Muscle Nerve"},{"issue":"12","key":"10.1016\/j.cca.2015.07.030_bb0090","doi-asserted-by":"crossref","first-page":"3334","DOI":"10.1073\/pnas.70.12.3334","article-title":"Studies on purified eel acetylcholine receptor and anti-acetylcholine receptor antibody","volume":"70","author":"Patrick","year":"1973","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.cca.2015.07.030_bb0095","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1017\/S0317167100026652","article-title":"Acetylcholine receptor antibodies in myasthenia gravis: use of a qualitative assay for diagnostic purposes","volume":"14","author":"Oger","year":"1987","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/j.cca.2015.07.030_bb0100","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1749-6632.1993.tb22877.x","article-title":"Thymus histology and acetylcholine receptor antibodies in generalized myasthenia gravis","volume":"681","author":"Oger","year":"1993","journal-title":"Ann N Y Acad Sci"},{"issue":"5","key":"10.1016\/j.cca.2015.07.030_bb0105","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1212\/WNL.38.5.818","article-title":"Antibody production by blood lymphocytes in myasthenia gravis: reduction in disease of long duration","volume":"38","author":"Kaufman","year":"1988","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.cca.2015.07.030_bb0110","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/ene.12270","article-title":"Antibodies to clustered acetylcholine receptor: expanding the phenotype","volume":"21","author":"Devic","year":"2014","journal-title":"Eur J Neurol"},{"issue":"Pt 7","key":"10.1016\/j.cca.2015.07.030_bb0115","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1093\/brain\/awn092","article-title":"IgG1 antibodies to acetylcholine receptors in \u2018seronegative\u2019 myasthenia gravis","volume":"131","author":"Leite","year":"2008","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.cca.2015.07.030_bb0185","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/85520","article-title":"Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies","volume":"7","author":"Hoch","year":"2001","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.cca.2015.07.030_bb0190","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1212\/01.wnl.0000228225.23349.5d","article-title":"Anti-MuSK antibodies: correlation with myasthenia gravis severity","volume":"67","author":"Bartoccioni","year":"2006","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.cca.2015.07.030_bb0130","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00415-011-6194-7","article-title":"Anti-LRP4 autoantibodies in AChR- and MuSK-antibody-negative myasthenia gravis","volume":"259","author":"Pevzner","year":"2012","journal-title":"J Neurol"},{"issue":"4","key":"10.1016\/j.cca.2015.07.030_bb0135","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1001\/archneurol.2011.2393","article-title":"Autoantibodies to lipoprotein-related protein 4 in patients with double-seronegative myasthenia gravis","volume":"69","author":"Zhang","year":"2012","journal-title":"Arch Neurol"},{"issue":"5","key":"10.1016\/j.cca.2015.07.030_bb0140","doi-asserted-by":"crossref","first-page":"945","DOI":"10.4049\/jimmunol.99.5.945","article-title":"Serum autoantibodies in myasthenia gravis and thymoma: selective affinity for I-bands of striated muscle as a guide to identification of antigen(s)","volume":"99","author":"Strauss","year":"1967","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.cca.2015.07.030_bb0145","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1365-2249.1990.tb05440.x","article-title":"Patients with myasthenia gravis and thymoma have in their sera IgG autoantibodies against titin","volume":"82","author":"Aarli","year":"1990","journal-title":"Clin Exp Immunol"},{"issue":"4","key":"10.1016\/j.cca.2015.07.030_bb0150","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/ane.12271","article-title":"Antititin antibody in early- and late-onset myasthenia gravis","volume":"130","author":"Szczudlik","year":"2014","journal-title":"Acta Neurol Scand"},{"issue":"6","key":"10.1016\/j.cca.2015.07.030_bb0155","first-page":"617","article-title":"Myasthenia gravis patients with ryanodine receptor antibodies have distinctive clinical features","volume":"14","author":"Romi","year":"2007","journal-title":"Eur Urol"},{"issue":"22","key":"10.1016\/j.cca.2015.07.030_bb0160","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1212\/WNL.0000000000000478","article-title":"Anti-agrin autoantibodies in myasthenia gravis","volume":"82","author":"Gasperi","year":"2014","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.cca.2015.07.030_bb0195","article-title":"Autoantibodies to agrin in myasthenia gravis patients","volume":"9","author":"Zhang","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.cca.2015.07.030_bb0170","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/j.1749-6632.1998.tb10972.x","article-title":"Rapsyn antibodies in myasthenia gravis","volume":"841","author":"Agius","year":"1998","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.cca.2015.07.030_bb0175","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/j.1749-6632.1998.tb10974.x","article-title":"Antirapsyn antibodies occur commonly in patients with lupus","volume":"841","author":"Agius","year":"1998","journal-title":"Ann N Y Acad Sci"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898115003599?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898115003599?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,12]],"date-time":"2023-08-12T19:18:26Z","timestamp":1691867906000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898115003599"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":34,"alternative-id":["S0009898115003599"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2015.07.030","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An update on laboratory diagnosis in myasthenia gravis","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2015.07.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2015.01.042","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}